Temas de la conferencia The inaugural ADC Target Selection Summit developed in collaboration with AstraZeneca, AbbVie, Mersana and Eisai is the industry’s definitive conference dedicated to exploring the importance of ADC target selection, discussing the validation of novel targets, understanding the patient population for a certain target and therefore developing life-changing ADCs.
